Stocks
Cara Therapeutics (CARA) EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| EBITDA, bln rub | ? | -88.2 | -83.8 | -117.7 | -62.6 | -26.7 | -33.4 | |
| Changes by years, y/y, % | -1 677% | -5% | +40% | -47% | -57% | |||
Cara Therapeutics. EBITDA US GAAP, bln rub
Cara Therapeutics. EBITDA US GAAP, changes, %
Cara Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Cara Therapeutics (CARA) EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 0.000 | -8.87 | -5.50 | -11.9 | -7.05 | -33.4 | |
| Changes by years, y/y, % | -100% | -51% | -47% | +119% | ||||
| Changes by quarters, q/q, % | -100% | -38% | +117% | -41% | ||||
